City of Hope develops tests to categorize pancreatic cancer risk
May 8, 2020 | By Katie Neith
Researchers led by Ajay Goel, Ph.D., M.S., have developed two new tests for assessing risk levels in people with pancreatic ductal adenocarcinoma, or PDAC. Such tests could lead to better personalized care for these patients and, therefore, potentially improved outcomes.
Patient Care | Research